Understanding gene polymorphisms in the renin-angiotensin system and endothelial nitric oxide synthase may help identify personalized treatment approaches for obese patients with arterial hypertension.
Should not yet change practice in obese hypertension; leaves open the role of RAS and eNOS polymorphisms for personalized therapy.
The review is dedicated to relationships between the blood pressure and body mass. Endothelial dysfunction and imbalance of neurohumoral systems, namely, the pathological increase in the activity of the renin-angiotensin system, in combination with obesity are the main mechanisms of the of the hypertonic disease pathogenesis. Here we discuss the research on polymorphism of the renin angiotensinic system genes and the endothelial synthase nitric oxide gene. The difficulty lies in the correct assessment of associations of alleles which have clinical significance. It is essential to determine precisely the associations of gene polymorphisms in the hypertonic disease with obesity. This provides an opportunity to identify new personified approaches to the treatment of patients with this complex pathology.
No takes yet. Share an insight, caveat, or question.
Ащеулова et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: